On the morning of October 28, the groundbreaking ceremony for Fuzhou Neuray Medical Isotope and Pharmaceutical Industrialization Project was grandly held at the Fuzhou New Area project site. Distinguished guests from the Fuzhou New Area Administrative Committee, Fujian Academy of Innovation, investment institutions and partners, project construction parties, as well as representatives from Neuray Medical's management team and staff attended the ceremony, jointly witnessing this important milestone in the construction of the Fuzhou Neuray project.

At the ceremony, Cai Jiming, Chairman of Newlight Medical, delivered the opening speech. He expressed gratitude to the leaders and partner organizations who have supported the establishment of Fuzhou Newlight Medical over the years, and pledged to strive for early completion and operation of the project to generate benefits as soon as possible. Lin Kuiran, Secretary of the Party Committee and President of Fujian Institute of Innovation, Chen Bin, Member of the Party Working Committee and Deputy Director of Fuzhou New Area Administrative Committee, Deputy Secretary of Changle District Party Committee, and Chen Ying, Chairman of Fujian Innovation and Entrepreneurship Investment Management Co., Ltd., also gave speeches respectively, expressing high expectations for the construction and development of Fuzhou Newlight Medical project.

Then, amidst a salute of guns and fluttering ribbons during the groundbreaking ceremony, the guests held golden shovels and jointly laid the foundation soil for Fuzhou Neurit's Medical Isotope and Pharmaceutical Industrialization Project. The freshly turned earth symbolized their enthusiasm for scientific research and innovation, while the laid foundation stones represented their confidence in the nuclear medicine industry.

The Fuzhou Neuray Medical Isotope and Pharmaceutical Industrialization Project is a positive practice and innovative model of industrial cooperation between Fuzhou New District and Neuray Medical. Relying on its parent company Neuray Medical's profound technological accumulation and rich R&D pipeline in the field of nuclear medicine, it mainly produces radioactive diagnostic and therapeutic drugs. Upon completion, it will become Neuray's production base for medical isotopes and pharmaceuticals in the Southeast market, which will help improve the regional nuclear medicine industry chain, promote the clinical application of cutting-edge nuclear medicine technologies, and inject strong impetus into the development of nuclear medicine and healthcare industry in the Southeast region!

Source: Newlight Medical